Gandotinib
id:
gandotinib-313-8799471
title:
Gandotinib
text:
Gandotinib (LY-2784544) is an experimental drug developed by Eli Lilly for treatment of cancer. It is a small molecule JAK2 inhibitor, with additional minor inhibition of STAT3. In phase I trial, 16% of patients receiving the drug developed tumor lysis syndrome. A phase II trial is underway for patients with myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, or myelofibrosis, who had failed ruxolitinib.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Gandotinib
date created:
date modified:
2024-03-29T23:13:21Z
main entity:
{"identifier":"Q27077770","url":"https://www.wikidata.org/entity/Q27077770"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/84/Gandotinib.svg","width":1700,"height":1210}
fields total:
13
integrity:
15